Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has transformed weight loss treatment by activating GLP-1 receptors in your brain to reduce hunger and increase fullness signals. The medication works best when doses are carefully titrated upward over weeks, allowing your body to adapt while achieving sustainable fat loss. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies, ensuring quality and affordability regardless of your starting dose level.

How Semaglutide Dosing Schedules Work for Weight Loss

Semaglutide treatment follows a structured titration protocol where doses begin at 0.25 mg once weekly and increase every four weeks. This gradual escalation helps your body adjust to the medication while reducing nausea, vomiting, and gastrointestinal discomfort that can occur with rapid dose jumps. Most patients progress through doses of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg over several months, though individual timelines vary based on tolerance and weight loss goals.

Your healthcare provider monitors your response during each four-week interval before recommending the next dose increase. Some patients reach their therapeutic dose at 1.0 mg weekly, while others benefit from continuing to 2.4 mg for greater appetite suppression and metabolic effects. The key principle is that your dose adjusts to match your individual needs—not a one-size-fits-all approach that ignores your body's signals.

Starting Dose vs. Maintenance Dose: Understanding the Difference

Your starting dose is intentionally low because semaglutide's therapeutic window is narrow, meaning small increases create significant effects on appetite and glucose metabolism. A 0.25 mg injection produces measurable GLP-1 receptor activation without overwhelming your system, allowing you to build tolerance over weeks. This conservative beginning protects against severe nausea and dropouts while building confidence in the medication's safety and effectiveness.

Your maintenance dose is the amount where you experience optimal weight loss with tolerable side effects—this is your personal sweet spot, not a predetermined target. Some patients stabilize at 1.0 mg and lose 10-15% of body weight, while others reach 2.4 mg and achieve 15-20% loss over one year of consistent use. PlexusDx supports both outcomes by providing your medication at the same monthly price regardless of which maintenance dose your provider selects.

Clinical Evidence: What Semaglutide Doses Actually Deliver

The STEP clinical trials demonstrated that semaglutide 2.4 mg weekly produced an average weight loss of 14.9% of baseline body weight over 68 weeks in adults with obesity. However, meaningful weight loss began appearing at doses as low as 0.5-1.0 mg, with average losses of 6-10% at these intermediate doses reported in real-world cohort studies. This evidence supports the concept that higher doses are not always necessary—your individual metabolism and GLP1R genetic variants influence how much semaglutide you need to activate sufficient appetite suppression.

Cardiovascular and metabolic benefits extend across the dosing range, including improved blood pressure, reduced triglycerides, and better insulin sensitivity even at lower maintenance doses. A 2023 analysis found that dose escalation beyond 1.7 mg produced diminishing returns for many patients, suggesting that 'more is not necessarily better' for sustainable, long-term weight management. This clinical reality aligns with PlexusDx's philosophy that personalized dosing—not maximum dosing—produces the best patient outcomes.

Why Price Should Not Change With Your Dose at PlexusDx

PlexusDx compounded semaglutide injections are priced at a flat $189/mo (or $149/mo on the 6-month plan) (with higher commitment tiers available), meaning whether your dose is 0.25 mg or 2.4 mg weekly, your monthly cost remains identical. This pricing model removes financial barriers to dose optimization and ensures patients aren't penalized for needing higher amounts to achieve their goals. Traditional pharmacy models that charge per-dose incentivize underdosing to lower costs, but PlexusDx structures pricing to align your financial incentive with your health outcomes.

All PlexusDx medications come from licensed 503A compounding pharmacies that operate under strict state and federal oversight, guaranteeing quality regardless of dose strength. HSA and FSA accounts cover PlexusDx compounded semaglutide, and no insurance or membership fees apply, making personalized dosing accessible to all 50 states. Your dose may need to go up as your body adapts, but your price won't—a commitment to transparent, patient-centered pricing that supports your long-term weight loss success.

Personalized Dosing and Genetic Testing: A Smarter Approach

Individual differences in semaglutide response stem partly from genetic variation in GLP1R (the receptor semaglutide binds to), GIPR (involved in glucose-dependent hormone response), and FTO (which influences appetite set point and metabolic rate). PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways and 49 peptides, revealing whether you're a rapid responder who thrives on lower doses or someone who benefits from advancing to higher maintenance doses. This genetic insight, available for $99 after your first month of treatment, transforms dosing from guesswork into precision medicine.

Patients with specific GLP1R and GIPR variants may experience stronger appetite suppression at lower doses, potentially reaching their weight loss goals at 1.0 mg without progressing to 2.4 mg. Others with FTO rs9939609 variants may require full-dose therapy to overcome their genetic tendency toward increased hunger and reduced satiety signals. PlexusDx's approach to genetic-informed dosing ensures you're not over-medicated or under-medicated—you're precisely dosed for your unique biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is a typical starting dose of semaglutide, and how long does titration take?

Semaglutide treatment begins with a 0.25 mg injection once weekly, with dose increases every four weeks (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg). Most patients reach their therapeutic dose within 8-16 weeks, though some advance faster or slower based on tolerance and weight loss response. PlexusDx supports your provider's dosing decisions at a flat monthly price, so advancing through the titration schedule never increases your cost.

How much weight can I expect to lose at different semaglutide dose levels?

Clinical data shows approximately 6-10% weight loss at doses of 0.5-1.0 mg weekly, 12-15% loss at 1.7 mg, and 14-18% loss at 2.4 mg over one year, though individual results vary significantly based on diet, exercise, and genetics. Your actual weight loss depends more on sustained lifestyle changes and how well semaglutide suppresses your hunger than on reaching the highest possible dose. Many patients achieve their goals at 1.0-1.7 mg and maintain excellent results without progressing to maximum dose.

Does PlexusDx charge more if my dose increases during treatment?

No. PlexusDx compounded semaglutide injections cost a flat $189/mo (or $149/mo on the 6-month plan) regardless of your weekly dose—whether you remain at 0.5 mg or advance to 2.4 mg, your monthly price stays the same. This transparent pricing ensures your dose is determined by your clinical needs and response, not by your budget concerns. Higher commitment tiers offer additional savings while maintaining the same flat price per dose level.

Are there risks to increasing semaglutide doses too quickly?

Rapid dose escalation increases nausea, vomiting, constipation, and dehydration risk, and may lead to medication discontinuation before you experience weight loss benefits. The standard four-week intervals between dose increases allow your body to adapt and your GLP-1 receptors to achieve steady-state activation, minimizing side effects while maximizing efficacy. Following your provider's recommended titration schedule—not rushing to higher doses—produces better long-term adherence and weight loss outcomes.

How can the PlexusDx Precision Peptide Genetic Test help optimize my semaglutide dose?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves